Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-28
2006-11-28
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S263000, C549S273000, C549S292000, C514S451000
Reexamination Certificate
active
07141602
ABSTRACT:
Lovastatin, pravastatin, simvastatin, mevastatin, atorvastatin, and derivatives and analogs thereof are known as HMG-CoA reductase inhibitors and are used as antihypercholesterolemic agents. The majority of them are produced by fermentation using microorganisms of different species identified as species belonging toAspergillus, Monascus, Nocardia, Amycolatopsis, MucororPenicilliumgenus,Streptomyces, Actinomadura, Micromonospora, some are obtained by treating the fermentation products using the method of chemical synthesis or they are the products of total chemical synthesis. The purity of the active ingredient is an important factor for manufacturing the safe and effective pharmaceutical, especially if the pharmaceutical product must be taken on a longer term basis in the treatment or prevention of high plasma cholesterol. The accumulation of the impurities from the pharmaceuticals of lower purity may cause many side effects during the medical treatment. The present invention relates to a new industrial process for the isolation of HMG-CoA reductase inhibitors using so-called displacement chromatography. Use of the invention enables one to obtain HMG-CoA reductase inhibitors of high purity, with high yields, lower production costs and suitable ecological balance.
REFERENCES:
patent: 4231938 (1980-11-01), Monaghan
patent: 5043423 (1991-08-01), Viscomi et al.
patent: 5202029 (1993-04-01), Haytko et al.
patent: 5420024 (1995-05-01), Carta et al.
patent: 5427686 (1995-06-01), Asher
patent: 5622985 (1997-04-01), Olukotun et al.
patent: 5798375 (1998-08-01), Tsujita et al.
patent: 6159997 (2000-12-01), Tsujita et al.
patent: 6218403 (2001-04-01), Daste et al.
patent: 6268186 (2001-07-01), Sibeijn et al.
patent: 6689590 (2004-02-01), Keri et al.
patent: 6695969 (2004-02-01), Grahek et al.
patent: 6936731 (2005-08-01), Keri et al.
patent: 0 416 416 (1991-03-01), None
patent: WO 92/16276 (1992-10-01), None
Horváth, Displacement Chromatography: Yesterday, Today and Tomorrow, Journal of Chromatography Library, vol. 32, pp. 179-203. 1985.
Brian Bidlingmeyer, Preparative Liquid Chromatography, Journal of Chromatography Library, vol. 38, pp. 12-13, 1987.
Cramer at al., Tandem use of Carboxypeptidase Y. Reactor and Displacement Chromatography for Peptide Synthesis, Journal of Chromatography, vol. 394, pp. 305-314 (1987).
Subramanian et al., Displacement Chromatography of Biomolecules, Journal of Chromatography, vol. 439, pp. 341-351 (1988).
Gu et al., Displacement Effect in Multicomponent Chromatography, AIChE Journal, vol. 36, pp. 1156-1162 (1990).
Felinger et al., Optimization of the experimental conditions and the column design partners in displacement chromatography, Journal of Chromatography vol. 609, pp. 35-47, (1992).
Frenz, Frontiers of Biopolymer Purification: Displacement Chromatography, LC-GC International, vol. 5, pp. 18-21, (1992).
Guiochon et al., Fundamentals of Preparative and Nonlinear Chromatography, pp. 301-303, Academic Press, © 1994.
Grahek et al., Chromatographic Purification of SINEGMG-CoA Reductase Inhibitors, Lek dd. Research and Development.
PCT/IB 99/01553 International Search Report.
Arai, et al.,Pravastatin Sodium(CS-514),A Novel Cholesterol Lowering Agent Which Inhibits HMG-CoA Reductase,Annu. Rep. Sankyo Res. Lab., 40; 1-38, 1988.
Bastarda Andrej
Grahek Rok
Milivojevic Dusan
Bromberg & Sunstein LLP
LEK Pharmaceuticals d.d.
Shameem Golam M. M.
LandOfFree
Process for obtaining HMG-CoA reductase inhibitors of high... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for obtaining HMG-CoA reductase inhibitors of high..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for obtaining HMG-CoA reductase inhibitors of high... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3673101